3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
32
Breast Neoplasms
25
Fallopian Tube Neoplasms
21
Multiple Myeloma
18
Carcinoma, Ovarian Epithelial
14
Lymphoma
8
Triple Negative Breast Neoplasms
4
Recurrence
3
Neoplasms, Plasma Cell
3
Hodgkin Disease
3
Prostatic Neoplasms
2
Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia
2
Hematologic Neoplasms
2
Burkitt Lymphoma
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Patient Participation
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neurofibrosarcoma
1
Interventions
fludarabine phosphate
18
Peripheral Blood Stem Cell Transplantation
15
Whole-Body Irradiation
14
Mycophenolic Acid
14
Cyclophosphamide
14
Tacrolimus
10
Cyclosporine
10
Busulfan
10
Antilymphocyte Serum
10
Methotrexate
8
Melphalan
7
Etoposide
7
Sirolimus
5
Radiotherapy
5
Filgrastim
5
Cord Blood Stem Cell Transplantation
5
Granulocyte Colony-Stimulating Factor
4
Cytarabine
4
Cyclosporins
4
thymoglobulin
3
Methylprednisolone
3
Therapeutics
2
Rituximab
2
Ondansetron
2
Flow Cytometry
2
Dexamethasone
2
Carmustine
2
Carboplatin
2
Calcium Dobesilate
2
Aprepitant
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
liposomal doxorubicin
×
Clear all
No trials found.